STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling

Published:2021-08 Issue: Volume:144 Page:155552
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Göder Anja,Ginter Torsten,Heinzel Thorsten,Stroh Svenja,Fahrer Jörg,Henke Andreas,Krämer Oliver H.

Funder

German Research Foundation

Wilhelm Sander Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference59 articles.

1. JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression;Owen;Cancers,2019

2. Transcriptional and chromatin regulation in interferon and innate antiviral gene expression;Au-Yeung;Cytokine Growth Factor Rev.,2018

3. Acetylation modulates the STAT signaling code;Wieczorek;Cytokine Growth Factor Rev.,2012

4. Paradigm shifts in the cell biology of STAT signaling;Sehgal;Semin. Cell Dev. Biol.,2008

5. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA;Chen;Cell,1998

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulated STAT1 gain-of-function: Pathogen-free autoimmunity and fungal infection;hLife;2024-08

2. Hsp90 inhibition leads to an increase in surface expression of multiple immunological receptors in cancer cells;Frontiers in Molecular Biosciences;2024-04-05

3. PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages;Cell Reports;2024-03

4. Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer;Pharmacological Reviews;2022-12-08

5. RIPK3 Promotes Hantaviral Replication by Restricting JAK-STAT Signaling but not Triggering Necroptosis.;2022-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3